Veterinary Cancer Vaccines: Proof-of-concept in dogs with B cell Lymphoma

Client-owned pet dogs represent exceptional translational models for advancement of Cancer Research, as they reflects the complex heterogeneity observed in human cancer. Takis and its network are specialized in monitoring the clinical and the immune response in patients treated with new therapies.

immune response graph1 650


overall survival 650 

Follow Us on Linkedin

Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity.